Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Advaxis Inc (ADXS)

Advaxis Inc (ADXS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,279
  • Shares Outstanding, K 66,227
  • Annual Sales, $ 20,880 K
  • Annual Income, $ -16,610 K
  • 60-Month Beta 3.48
  • Price/Sales 1.22
  • Price/Cash Flow N/A
  • Price/Book 0.75
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.40
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/14/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3400 +14.18%
on 09/25/20
0.5500 -29.42%
on 08/28/20
-0.0739 (-15.99%)
since 08/25/20
3-Month
0.3400 +14.18%
on 09/25/20
0.6600 -41.18%
on 07/21/20
-0.1988 (-33.87%)
since 06/25/20
52-Week
0.2480 +56.53%
on 09/30/19
1.4800 -73.77%
on 01/07/20
+0.1111 (+40.09%)
since 09/25/19

Most Recent Stories

More News
Advaxis Announces FDA Clearance of New IND for ADXS-504 for Treatment of Prostate Cancer

Strategic transition to Investigator sponsored IND from previously announced Advaxis sponsored IND

ADXS : 0.3882 (+5.89%)
Advaxis: Fiscal 3Q Earnings Snapshot

PRINCETON, N.J. (AP) _ Advaxis Inc. (ADXS) on Thursday reported a loss of $5.8 million in its fiscal third quarter.

ADXS : 0.3882 (+5.89%)
Advaxis Reports Third Quarter Ended July 31, 2020 Financial Results and Provides a Business Update

Strategic expansion of ADXS-503 HOT program in NSCLC to explore potential to enhance and or restore sensitivity to checkpoint inhibitors

ADXS : 0.3882 (+5.89%)
Advaxis Announces Resignation of Chief Financial Officer

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced that Molly Henderson, Executive Vice President...

ADXS : 0.3882 (+5.89%)
LD Micro - 360 Companies Set to Present this Week

LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACRX : 1.4900 (unch)
ACER : 2.54 (+6.72%)
ACU : 22.54 (+1.67%)
AT.VN : 1.610 (-0.62%)
AEY : 1.9000 (-1.55%)
ADIL : 1.2100 (unch)
ADTX : 1.8300 (+7.33%)
ADXS : 0.3882 (+5.89%)
AEHR : 1.5300 (+6.99%)
AIM : 2.15 (+5.91%)
AIRI : 1.1000 (-1.79%)
ALIM : 5.05 (unch)
ALJJ : 0.7600 (+1.35%)
ALLT : 8.68 (-0.69%)
ARCT : 40.09 (+6.94%)
AREC : 1.4900 (+7.19%)
AMS : 1.9300 (+14.88%)
ANVS : 4.50 (+1.12%)
APEN : 1.4100 (-1.40%)
APM : 1.3100 (+4.80%)
AQMS : 0.8849 (+2.30%)
AQB : 4.65 (+9.41%)
ARTL : 0.7101 (-0.31%)
ARHH : 0.7907 (-3.57%)
ATOM : 10.12 (+7.09%)
ATOS : 2.42 (+4.76%)
AUTO : 2.95 (+1.37%)
AYRO : 2.90 (+3.20%)
AZRX : 0.7219 (-1.77%)
BELFA : 10.90 (+8.46%)
BCDA : 2.37 (-1.25%)
BIOC : 4.20 (-2.33%)
BHTG : 1.2400 (+1.64%)
BIOL : 0.2800 (-1.96%)
BKEP : 1.4800 (+3.28%)
ATDS : 0.0082 (-1.20%)
ASUR : 6.98 (+1.16%)
BEER.VN : 0.060 (+9.09%)
ANY : 2.65 (-0.38%)
Advaxis to Present Corporate Overview at the LD Micro 500 Virtual Conference

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that Kenneth A. Berlin, President and Chief...

ADXS : 0.3882 (+5.89%)
LD Micro Announces Preliminary List of Presenters for the LD 500

LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACER : 2.54 (+6.72%)
ACU : 22.54 (+1.67%)
AEY : 1.9000 (-1.55%)
ADIL : 1.2100 (unch)
ADXS : 0.3882 (+5.89%)
AEHR : 1.5300 (+6.99%)
AIM : 2.15 (+5.91%)
AIRI : 1.1000 (-1.79%)
KERN : 3.60 (-1.10%)
ALIM : 5.05 (unch)
ALLT : 8.68 (-0.69%)
AMS : 1.9300 (+14.88%)
ANVS : 4.50 (+1.12%)
APEN : 1.4100 (-1.40%)
APM : 1.3100 (+4.80%)
AQB : 4.65 (+9.41%)
ARTL : 0.7101 (-0.31%)
ARHH : 0.7907 (-3.57%)
ATOM : 10.12 (+7.09%)
ATOS : 2.42 (+4.76%)
ACU.VN : 0.150 (+7.14%)
AUTO : 2.95 (+1.37%)
AYRO : 2.90 (+3.20%)
AYTU : 1.1800 (-1.67%)
AZRX : 0.7219 (-1.77%)
BLDP : 14.26 (+0.28%)
BELFA : 10.90 (+8.46%)
BCDA : 2.37 (-1.25%)
BIOC : 4.20 (-2.33%)
BMRA : 7.10 (+6.93%)
BSGM : 5.22 (+8.30%)
BLNK : 8.52 (+10.65%)
BKEP : 1.4800 (+3.28%)
CLBS : 1.7500 (+5.42%)
CLXT : 6.12 (-1.77%)
ASUR : 6.98 (+1.16%)
BLGO : 0.1516 (+2.43%)
Advaxis Announces Common Stock Purchase Agreement for up to $20 Million with Lincoln Park Capital

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced that it has entered into a common stock purchase...

LPBC : 6.3100 (+0.48%)
ADXS : 0.3882 (+5.89%)
Advaxis to be Featured in "Grand Rounds: a Webinar in Biotech and Specialty Pharma," Hosted by Alliance Global Partners

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products, today announced that Kenneth A. Berlin, President and Chief...

ADXS : 0.3882 (+5.89%)
Advaxis: Fiscal 2Q Earnings Snapshot

PRINCETON, N.J. (AP) _ Advaxis Inc. (ADXS) on Thursday reported a loss of $6.3 million in its fiscal second quarter.

ADXS : 0.3882 (+5.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade ADXS with:

Business Summary

Advaxis, Inc. is a development stage biotechnology company focused on developing safe and effective cancer vaccines that utilize multiple mechanisms of immunity. The Company is developing a live Listeria vaccine technology under license from the University of Pennsylvania which secretes a protein sequence...

See More

Key Turning Points

2nd Resistance Point 0.4347
1st Resistance Point 0.4115
Last Price 0.3882
1st Support Level 0.3525
2nd Support Level 0.3167

See More

52-Week High 1.4800
Fibonacci 61.8% 1.0094
Fibonacci 50% 0.8640
Fibonacci 38.2% 0.7186
Last Price 0.3882
52-Week Low 0.2480

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar